4
Changes in Ownership
Matinas BioPharma Holdings, Inc. Filed Acc 0000905718-21-001609
Options or other derivatives
- Chief Scientific Officer acquired 275,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
MANNINO RAPHAEL J · Chief Scientific Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-12-14 | Grant or award : show line 1 in the form Stock Option (right to Buy) | +275,000 | 275,000 | D |
Loading xslF345X03/matinas_fm4dec152021.xml…